한글목차

유럽의 흉터 관리 시장 규모는 2023년 2억 3,850만 달러에 달했습니다.

이 시장은 2030년에는 3억 5,100만 달러에 달할 것으로 예측되며, 예측기간인 2023년부터 2030년까지 CAGR은 5.67%가 될 것으로 보입니다. 유럽에서의 흉터 관리 시장 확대는 수술, 사고 및 화상으로 인한 흉터의 유병률 증가로 효과적인 관리 솔루션에 대한 수요가 증가함에 따라 추진될 것으로 예상됩니다.

유럽의 흉터 관리 시장은 끊임없는 기술 혁신과 수술, 부상, 피부 트러블로 인한 흉터 치료의 중요성이 특징입니다. 위축성 흉터, 두꺼운 흉터, 켈로이드 흉터, 구축 흉터, 선형 피부 위축 등 효과적인 흉터 관리 치료에 대한 수요가 증가함에 따라 시장이 급속히 확대되고 있습니다.

현재 진행중인 연구와 의료 관계자, 업계 이해 관계자간의 협력과 함께 규제 개발이 유럽의 흉터 관리 시장을 뒷받침하고 있습니다. 이러한 노력은 흉터 개선의 선택을 요구하는 고객의 요구 변화에 대응할 수 있도록 시장이 진화하고 있기 때문에 미래가 유망하다는 것을 보여줍니다.

그러나 복잡한 규제 프레임워크을 극복하고 혁신적인 의약품의 저렴한 가격과 가용성을 보장하는 문제는 여전히 남아 있습니다. 하지만 이 시장은 기술적 개선과 지속적인 연구 이니셔티브를 활용한 독자적인 상품과 치료법의 개발에 의해 기업이 차별화를 도모할 수 있는 큰 가능성을 가지고 있습니다.

전반적으로 유럽의 흉터 관리 시장은 인지도 향상, 소비자 선호도 변화, 보다 효과적인 흉터 개선 제품의 끊임없는 추구로 성장과 변화를 이루려고 합니다.

본 보고서에서는 유럽의 흉터 관리 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 흉터 유형별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

주요 요약

제1장 시장

제2장 업계 전망

• 시장 개요
• 시장 동향
• COVID-19에 의한 흉터 관리에 대한 영향
• 공급망 분석
• 구매 채널
• 상환 시나리오

제3장 유럽

• 개요
• 유럽
  • 법적 틀 및 규제 요건
  • 시장 역학
  • 시장 규모 및 예측

제4장 시장-경쟁 벤치마킹 및 기업 프로파일

• 경쟁 구도
  • 개요
  • 비즈니스 전략
• 흉터 관리 생태계의 액티브 기업
• 기업 프로파일
  • Advancis Medical
  • Bayer AG
  • B. Braun SE
  • Molnlycke Health Care AB
  • Smith & Nephew
  • Stratpharma AG

영문목차

Introduction to Europe Scar Management Market

The Europe scar management market was valued at $238.5 million in 2023 and is anticipated to reach $351.0 million by 2030, witnessing a CAGR of 5.67% during the forecast period 2023-2030. The expansion of the scar management market in Europe is anticipated to be propelled by the rising prevalence of scars resulting from surgeries, accidents, and burns, leading to heightened demand for effective management solutions.

Market Introduction

The scar management market in Europe is characterized by continuous innovation and an increasing emphasis on treating scars caused by surgeries, injuries, or skin problems. The market is expanding rapidly in response to increased demand for effective scar management treatments, such as atrophic, hypertrophic, keloid, contracture scars, and stretch marks.

Regulatory developments, combined with ongoing research and collaboration among medical professionals and industry stakeholders, are propelling the scar management market in Europe. These initiatives indicate a promising future as the market evolves to meet the changing needs of customers looking for scar enhancement options.

However, challenges such as navigating complex regulatory frameworks and guaranteeing the affordability and accessibility of innovative medicines remain. Nonetheless, the market provides significant potential for companies to differentiate themselves by developing unique goods and therapies that use technological improvements and ongoing research initiatives.

Overall, the scar management market in Europe is primed for growth and transition, owing to rising awareness, shifting consumer preferences, and a relentless pursuit of more effective scar-enhancing products.

Market Segmentation:

Segmentation 1: by Product

• Silicon Gel and Spray
• Silicon Dressing
• Cream and Ointment
• Others

Segmentation 2: by Scar Type

• Atrophic Scars
• Hypertrophic and Keloid Scars
• Others

Segmentation 3: by End User

• Hospitals
• Specialty Clinics
• Home Healthcare (Over-the-Counter (OTC))

Segmentation 4: by Region

• Europe - Germany, U.K., France, Spain, Italy, Portugal, Netherlands, Ireland, Belgium, Switzerland, Norway, Denmark, Sweden, Finland, Czech Republic, Russian Federation, Poland, Austria, Romania, Slovakia, Greece, Turkiye, and Ukraine

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe scar management market (by scar type) comprises atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. Moreover, the study provides the reader with a detailed understanding of the various types of scars and associated products tailored to address these scars.

Growth/Marketing Strategy: The Europe scar management market's growth strategy includes innovation, expansion into emerging markets, collaboration with healthcare professionals, and regulatory streamlining. These efforts aim to enhance accessibility and meet the diverse needs of consumers.

Competitive Strategy: Key players in the Europe scar management market have been analyzed and profiled in the study, including new product launches and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe scar management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

• Advancis Medical
• Bayer AG
• B. Braun S.E.
• Molnlycke Health Care AB
• Smith & Nephew
• Stratpharma AG

Table of Contents

Executive Summary

Scope of the Report

Research Methodology

1 Market

• 1.1 Product Definition
• 1.2 Inclusion Criteria for the Report
• 1.3 Exclusion Criteria for the Report
• 1.4 Key Findings

2 Industry Outlook

• 2.1 Market Overview
• 2.2 Market Trends
• 2.3 Impact of COVID-19 on Scar Management
• 2.4 Supply Chain Analysis
  • 2.4.1 Key Entities in Supply Chain
• 2.5 Purchasing Channels
• 2.6 Reimbursement Scenario
  • 2.6.1 Reimbursement Scenario in Europe

3 Europe

• 3.1 Overview
• 3.2 Europe
  • 3.2.1 Legal Framework and Regulatory Requirement
  • 3.2.2 Market Dynamics
  • 3.2.3 Market Sizing and Forecast
    • 3.2.3.1 Europe Scar Management Market (by Product)
    • 3.2.3.2 Europe Scar Management Market (by Scar Type)
    • 3.2.3.3 Europe Scar Management Market (by End User)
    • 3.2.3.4 Europe Scar Management Market, (by Country)
      • 3.2.3.4.1 Germany
        • 3.2.3.4.1.1 Market Dynamics
        • 3.2.3.4.1.2 Market Sizing and Forecast
        • 3.2.3.4.1.2.1 Germany Scar Management Market (by Product)
      • 3.2.3.4.2 France
        • 3.2.3.4.2.1 Market Dynamics
        • 3.2.3.4.2.2 Market Sizing and Forecast
        • 3.2.3.4.2.2.1 France Scar Management Market (by Product)
      • 3.2.3.4.3 U.K.
        • 3.2.3.4.3.1 Market Dynamics
        • 3.2.3.4.3.2 Market Sizing and Forecast
        • 3.2.3.4.3.2.1 U.K. Scar Management Market (by Product)
      • 3.2.3.4.4 Italy
        • 3.2.3.4.4.1 Market Dynamics
        • 3.2.3.4.4.2 Market Sizing and Forecast
        • 3.2.3.4.4.2.1 Italy Scar Management Market (by Product)
      • 3.2.3.4.5 Spain
        • 3.2.3.4.5.1 Market Dynamics
        • 3.2.3.4.5.2 Market Sizing and Forecast
        • 3.2.3.4.5.2.1 Spain Scar Management Market (by Product)
      • 3.2.3.4.6 Portugal
        • 3.2.3.4.6.1 Market Dynamics
        • 3.2.3.4.6.2 Market Sizing and Forecast
        • 3.2.3.4.6.2.1 Portugal Scar Management Market (by Product)
      • 3.2.3.4.7 Netherlands
        • 3.2.3.4.7.1 Market Dynamics
        • 3.2.3.4.7.2 Market Sizing and Forecast
        • 3.2.3.4.7.2.1 Netherland Scar Management Market (by Product)
      • 3.2.3.4.8 Ireland
        • 3.2.3.4.8.1 Market Dynamics
        • 3.2.3.4.8.2 Market Sizing and Forecast
        • 3.2.3.4.8.2.1 Ireland Scar Management Market (by Product)
      • 3.2.3.4.9 Belgium
        • 3.2.3.4.9.1 Market Dynamics
        • 3.2.3.4.9.2 Market Sizing and Forecast
        • 3.2.3.4.9.2.1 Belgium Scar Management Market (by Product)
      • 3.2.3.4.10 Switzerland
        • 3.2.3.4.10.1 Market Dynamics
        • 3.2.3.4.10.2 Market Sizing and Forecast
        • 3.2.3.4.10.2.1 Switzerland Scar Management Market (by Product)
      • 3.2.3.4.11 Norway
        • 3.2.3.4.11.1 Market Dynamics
        • 3.2.3.4.11.2 Market Sizing and Forecast
        • 3.2.3.4.11.2.1 Norway Scar Management Market (by Product)
      • 3.2.3.4.12 Denmark
        • 3.2.3.4.12.1 Market Dynamics
        • 3.2.3.4.12.2 Market Sizing and Forecast
        • 3.2.3.4.12.2.1 Denmark Scar Management Market (by Product)
      • 3.2.3.4.13 Sweden
        • 3.2.3.4.13.1 Market Dynamics
        • 3.2.3.4.13.2 Market Sizing and Forecast
        • 3.2.3.4.13.2.1 Sweden Scar Management Market (by Product)
      • 3.2.3.4.14 Finland
        • 3.2.3.4.14.1 Market Dynamics
        • 3.2.3.4.14.2 Market Sizing and Forecast
        • 3.2.3.4.14.2.1 Finland Scar Management Market (by Product)
      • 3.2.3.4.15 Czech Republic
        • 3.2.3.4.15.1 Market Dynamics
        • 3.2.3.4.15.2 Market Size and Forecast
        • 3.2.3.4.15.2.1 Czech Republic Scar Management Market (by Product)
      • 3.2.3.4.16 Russian Federation
        • 3.2.3.4.16.1 Market Dynamics
        • 3.2.3.4.16.2 Market Size and Forecast
        • 3.2.3.4.16.2.1 Russia Federation Scar Management Market (by Product)
      • 3.2.3.4.17 Poland
        • 3.2.3.4.17.1 Market Dynamics
        • 3.2.3.4.17.2 Market Size and Forecast
        • 3.2.3.4.17.2.1 Poland Scar Management Market (by Product)
      • 3.2.3.4.18 Austria
        • 3.2.3.4.18.1 Market Dynamics
        • 3.2.3.4.18.2 Market Size and Forecast
        • 3.2.3.4.18.2.1 Austria Scar Management Market (by Product)
      • 3.2.3.4.19 Romania
        • 3.2.3.4.19.1 Market Dynamics
        • 3.2.3.4.19.2 Market Size and Forecast
        • 3.2.3.4.19.2.1 Romania Scar Management Market (by Product)
      • 3.2.3.4.20 Slovakia
        • 3.2.3.4.20.1 Market Dynamics
        • 3.2.3.4.20.2 Market Size and Forecast
        • 3.2.3.4.20.2.1 Slovakia Scar Management Market (by Product)
      • 3.2.3.4.21 Greece
        • 3.2.3.4.21.1 Market Dynamics
        • 3.2.3.4.21.2 Market Size and Forecast
        • 3.2.3.4.21.2.1 Greece Scar Management Market (by Product)
      • 3.2.3.4.22 Turkiye
        • 3.2.3.4.22.1 Market Dynamics
        • 3.2.3.4.22.2 Market Size and Forecast
        • 3.2.3.4.22.2.1 Turkiye Scar Management Market (by Product)
      • 3.2.3.4.23 Ukraine
        • 3.2.3.4.23.1 Market Dynamics
        • 3.2.3.4.23.2 Market Size and Forecast
        • 3.2.3.4.23.2.1 Ukraine Scar Management Market (by Product)

4 Markets - Competitive Benchmarking & Company Profiles

• 4.1 Competitive Landscape
  • 4.1.1 Overview
  • 4.1.2 Business Strategies
    • 4.1.2.1 Product Launches/Approvals
• 4.2 Scar Management Ecosystem Active Players
• 4.3 Company Profiles
  • 4.3.1 Advancis Medical
    • 4.3.1.1 Company Overview
    • 4.3.1.2 Role of Advancis Medical in the Scar Management Market
    • 4.3.1.3 Analyst Perspectives
  • 4.3.2 Bayer AG
    • 4.3.2.1 Company Overview
    • 4.3.2.2 Role of Bayer AG in the Scar Management Market
    • 4.3.2.3 Financials
    • 4.3.2.4 Target Customers
    • 4.3.2.5 Analyst Perspectives
  • 4.3.3 B. Braun S.E.
    • 4.3.3.1 Company Overview
    • 4.3.3.2 Role of B. Braun S.E. in the Scar Management Market
    • 4.3.3.3 Financials
    • 4.3.3.4 Target Customers
    • 4.3.3.5 Analyst Perspectives
  • 4.3.4 Molnlycke Health Care AB
    • 4.3.4.1 Company Overview
    • 4.3.4.2 Role of Molnlycke Health Care AB in the Scar Management Market
    • 4.3.4.3 Financials
    • 4.3.4.4 Target Customers
    • 4.3.4.5 Analyst Perspectives
  • 4.3.5 Smith & Nephew
    • 4.3.5.1 Company Overview
    • 4.3.5.2 Role of Smith & Nephew in the Scar Management Market
    • 4.3.5.3 Financials
    • 4.3.5.4 Target Customers
    • 4.3.5.5 Analyst Perspectives
  • 4.3.6 Stratpharma AG
    • 4.3.6.1 Company Overview
    • 4.3.6.2 Role of Stratpharma AG in the Scar Management Market
    • 4.3.6.3 Target Customers
    • 4.3.6.4 Analyst Perspectives